Icon Overview

  • Founded
  • 1990
Founded
  • Status
  • Public
  • Employees
  • 15,250
Employees
  • Stock Symbol
  • ICLR
Stock Symbol
  • Investments
  • 29
  • Share Price
  • $217.93
  • (As of Thursday Closing)

Icon General Information

Description

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Contact Information

Website
www.iconplc.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • South County Business Park
  • Leopardstown
  • Dublin 18
  • Ireland
+353 (01) 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Icon Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$217.93 $220.96 $104.28 - $223.62 $11.7B 52.8M 199K $6.06

Icon Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 9,876,862 9,231,210 6,891,354 6,129,484
Revenue 2,762,468 2,805,839 2,595,777 1,758,439
EBITDA 451,656 494,956 439,273 399,635
Net Income 330,104 373,986 322,656 281,488
Total Assets 3,065,298 2,907,512 2,354,255 2,146,618
Total Debt 412,417 454,553 349,264 348,888
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Icon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Icon‘s full profile, request access.

Request a free trial

Icon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to
Drug Discovery
Dublin, Ireland
15,250 As of 2020
00000
000000000 00000

0000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000 000000000
Newton, MA
0000 As of 0000
00.000
000000000 00.000

0000000

strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000 000000000
Kansas City, MO
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Icon Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Parexel International Private Equity-Backed Newton, MA 0000 00.000 000000000 00.000
0000000 00000000 Corporate Backed or Acquired Kansas City, MO 000000&0
00000000000000 000 Private Equity-Backed Wilmington, NC 00000 00.000 00000000000 00.000
0000 000000 Formerly PE-Backed Shanghai, China 00000 00.000 000000000 00.000
0000000 00000 0000 Formerly PE-Backed Wilmington, MA 00000 00000 00000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Icon Executive Team (15)

Name Title Board Seat Contact Info
Steven Cutler Ph.D Board Member, Chief Executive Officer and Chief Operating Officer
Nuala Murphy Ph.D President, Clinical Research Services
Brendan Brennan Chief Financial Officer, Finance
Diarmaid Cunningham Chief Administrative Officer, Administration & Executive Vice President
Thomas O'Leary Chief Information Officer
You’re viewing 5 of 15 executive team members. Get the full list »

Icon Board Members (11)

Name Representing Role Since
000000 000000 00 Icon Chairman & Board Member 000 0000
000000 0000000 Self Board Member 000 0000
0000 00000 Self Board Member 000 0000
0000 000000 00.0 Icon Founder & Board Member 000 0000
0000 0000000000 00 Icon Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Icon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Icon Investments & Acquisitions (29)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 19-Feb-2020 000000000000000000 000.00 Practice Management (Healthcare) 000000 000000 00.0
00000000 00000000 24-Sep-2019 000000000000000000 000.00 Clinics/Outpatient Services 000000 000000 00.0
00000000 00000000 23-May-2019 000000000000000000 000.00 Other Healthcare Services 000000 000000 00.0
00000000000 21-Feb-2019 000000000000000000 000.00 Biotechnology 000000 000000 00.0
Mapi 27-Jul-2017 Merger/Acquisition Other Commercial Services 000000 000000 00.0
You’re viewing 5 of 29 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Icon Subsidiaries (10)

Company Name Industry Location Founded
MolecularMD Biotechnology Portland, OR 2005
00000000 00000000 Clinics/Outpatient Services Vernon Hills, IL 0000
0000 0000000000000 Human Capital Services Amstelveen, Netherlands 0000
0000 0000000000 00 Other Healthcare Services Hinckley, OH 0000
0000000000 0000000 Clinics/Outpatient Services San Antonio, TX 0000
You’re viewing 5 of 10 subsidiaries. Get the full list »

Icon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 09-Jul-2009 000000000000000000 Completed
  • 0000
To view Icon’s complete exits history, request access »